8-K 1 item502_21014.htm 8-K Item 5.02_2.10.14


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 4, 2014
Accretive Health, Inc.
 
(Exact Name of Registrant as Specified in Charter)
Delaware
 
001-34746
 
02-0698101
 
 
 
 
 
(State or Other Juris-
diction of Incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

401 North Michigan Avenue, Suite 2700, Chicago, Illinois
 
60611
 
 
 
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant's telephone number, including area code: (312) 324-7820

 
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
 
o
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
 
o
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
 
o
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 5.02     Departure of Directors or Certain Officer; Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers


On February 4, 2014, Miles McHugh, Senior Vice President, Chief Accounting Officer, of the Company notified the Company that he has decided not to accept the Company’s offer to relocate him and his family to Dallas, Texas in connection with the restructuring plan described in Item 2.05 of the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 24, 2014, and therefore he will leave the Company, effective September 30, 2014 (the “Departure Date”). Mr. McHugh will continue to perform his duties until the Departure Date.






SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 
 
ACCRETIVE HEALTH, INC.
 
 
 
 
Date: February 10, 2014
 
 
 
By:
 
/s/ Sean F. Orr
 
 
 
 
 
 
Sean F. Orr
 
 
 
 
 
 
Chief Financial Officer and Treasurer